This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Cefuroxime 750 mg powder for solution for injection/infusion PA2059/006/001 Fresenius Kabi Deutschland GmbH | Cefuroxime |
| CHOLESTAGEL 625 mg FILM-COATED tablets EU/1/03/268/1-3 CHEPLAPHARM Arzneimittel GmbH | Colesevelam |
| Clindamycin 150 mg/ml solution for injection PA2059/007/001 Fresenius Kabi Deutschland GmbH | Clindamycin |
| Clonocid 250 mg film-coated Tablets PA0126/136/001 Clonmel Healthcare Ltd | Clarithromycin |
| Monopost Unidose 50 micrograms/ml eye drops, solution in single-dose container PA1107/007/001 Laboratoires Thea | Latanoprost |
| Remifentanil Noridem 2 mg powder for concentrate for solution for injection or infusion PA1122/014/002 Noridem Enterprises Limited | Remifentanil |
| Remifentanil Noridem 5 mg powder for concentrate for solution for injection or infusion PA1122/014/003 Noridem Enterprises Limited | Remifentanil |
| Vancomycin Viatris 500 mg, powder for solution for infusion PA23266/004/001 Viatris Limited | Vancomycin |
| Zovirax IV for Infusion 250 mg, Powder for solution for infusion PA1077/084/003 GlaxoSmithKline (Ireland) Limited | Aciclovir |
| Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for injection (7.5mg/5ml) EU/1/00/170/002 Sanofi Winthrop Industrie | Rasburicase |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Clonocid 500 mg film-coated tablets PA0126/136/002 Clonmel Healthcare Ltd | Clarithromycin |
| Creon 10000 Gastro-resistant Capsules PA23355/006/001 Viatris Healthcare Limited | Lipase & Amylase & Protease |
| Creon 25000 Gastro-resistant Capsules PA23355/006/002 Viatris Healthcare Limited | Lipase & Amylase & Protease |
| Etoposide 20 mg/ml concentrate for solution for infusion PA2059/036/001 Fresenius Kabi Deutschland GmbH | Etoposide |
| Ezetimibe Teva 10 mg tablets PA1986/012/001 Teva B.V. | Ezetimibe |
| Montelukast Viatris 5 mg Chewable Tablets PA23266/022/002 Viatris Limited | Montelukast |
| Orencia 125mgSolution for injection in pre-filled pen EU/1/07/389/011-012 Bristol-Myers Squibb Pharma EEIG | Abatacept |
| Ozempic0.25 mg solution for injection in pre-filled pen EU/1/17/1251/002 Novo Nordisk A/S | Semaglutide |
| Ozempic0.5 mg solution for injection in pre-filled pen EU/1/17/1251/003-003
Novo Nordisk A/S
| Semaglutide |
| Pentasa 1g Suppositories PA1009/006/002 Ferring Ireland Ltd | Mesalazine |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.